Neural contribution to the effect of glucagon-like peptide-1-(7—36) amide on arterial blood pressure in rats

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

A role for glucagon-like peptide-1 in the central regulation of feeding

Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · see citing works

Glucagon-like peptide-1 7–36: a physiological incretin in man

Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928 · see citing works

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906 · see citing works

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.

Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903 · see citing works

Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing

Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724 · see citing works

Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man

Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316798 · Cited by 670 · see citing works

Hamster preproglucagon contains the sequence of glucagon and two related peptides

Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649 · see citing works

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats

Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597 · see citing works

Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites

Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · see citing works

Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences

Wei, Y., & Mojsov, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01430-9 · Cited by 450 · see citing works

Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse.

Campos, R. V., Lee, Y. C., & Drucker, D. J. (1994) · Endocrinology · doi:10.1210/endo.134.5.8156917 · Cited by 342 · see citing works

Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study

Jin, S.-L. C., Han, V. K. M., Simmons, J. G., Towle, A. C., Lauder, J. M., & Lund, P. K. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902710405 · Cited by 335 · see citing works

Glucagon-Like Peptide I Receptors in the Subfornical Organ and the Area Postrema Are Accessible to Circulating Glucagon-Like Peptide I

Ørskov, C., Poulsen, S. S., Mørten, M., & Holst, J. J. (1996) · Diabetes · doi:10.2337/diab.45.6.832 · Cited by 303 · see citing works

Cardiovascular effects of glucagon in man

Parmley, W. W., Glick, G., & Sonnenblick, E. H. (1968) · New England Journal of Medicine · doi:10.1056/nejm196807042790103 · Cited by 246 · see citing works

Colocalization of Glucagon‐Like Peptide‐1 (GLP‐1) Receptors, Glucose Transporter GLUT‐2, and Glucokinase mRNAs in Rat Hypothalamic Cells: Evidence for a Role of GLP‐1 Receptor Agonists as an Inhibitory Signal for Food and Water Intake

Navarro, M. A., de Fonseca, F. R., Álvarez, E., Chowen, J. A., Zueco, J. A., Gomez, R., Eng, J., & Blázquez, E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051982.x · Cited by 233 · see citing works

Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats.

Barragán, J., Rodríguez, R. E., & Blázquez, E. (1994) · American Journal of Physiology · doi:10.1152/ajpendo.1994.266.3.e459 · Cited by 207 · see citing works

Central representation of visceral function.

Cechetto, D. F. (1987) · PubMed · Cited by 198 · see citing works

Expression of the Glucagon‐Like Peptide‐1 Receptor Gene in Rat Brain

Alvarez, E., Roncero, I., Chowen, J. A., Thorens, B., & Blázquez, E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66030920.x · Cited by 194 · see citing works

Identification and Localization of Glucagon-Like Peptide-1 and Its Receptor in Rat Brain*

Shimizu, I., Hirota, M., Ohboshi, C., & Shima, K. (1987) · Endocrinology · doi:10.1210/endo-121-3-1076 · Cited by 174 · see citing works

Receptors for glucagon-like peptide-1(7–36) amide on rat insulinoma-derived cells

Göke, R., & Conlon, J. M. (1988) · Journal of Endocrinology · doi:10.1677/joe.0.1160357 · Cited by 153 · see citing works

Interactions of exendin-(9-39) with the effects of glucagon-like peptide-1-(7-36) amide and of exendin-4 on arterial blood pressure and heart rate in rats.

Barragán, J., Rodríguez, R. E., Eng, J., & Blázquez, E. (1996) · Regulatory Peptides · doi:10.1016/s0167-0115(96)00113-9 · Cited by 127 · see citing works

Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4.

Raufman, J., Singh, L., Singh, G., & Eng, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36628-1 · Cited by 122 · see citing works

Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia

Sainsbury, A., Rohner-Jeanrenaud, F., Cusin, I., Zakrzewska, K. E., Halban, P. A., Gaillard, R. C., & Jeanrenaud, B. (1997) · Diabetologia · doi:10.1007/s001250050820 · Cited by 115 · see citing works

Identification and characterization of glucagon‐like peptide‐1 7–36 amide‐binding sites in the rat brain and lung

Kanse, S. M., Kreymann, B., Ghatei, M. A., & Bloom, S. R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81063-9 · Cited by 104 · see citing works

Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus

Kreymann, B., Ghatei, M. A., Burnet, P. W. J., Williams, G., Kanse, S. M., Diani, A. R., & Bloom, S. R. (1989) · Brain Research · doi:10.1016/0006-8993(89)90628-8 · Cited by 102 · see citing works

Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue

Valverde, I., Mérida, E., Delgado, E., Trapote, M. A., & Villanueva‐Peñacarrillo, M. L. (1993) · Endocrinology · doi:10.1210/endo.132.1.8380388 · Cited by 96 · see citing works

Autoradiographic localization of receptors for glucagon-like peptide-1(7–36) amide in rat brain

UTTENTHAL, L. O., Tolédano, A., & Blázquez, E. (1992) · Neuropeptides · doi:10.1016/0143-4179(92)90036-v · Cited by 87 · see citing works

The area postrema: a cardiovascular control centre at the blood-brain interface?

Ferguson, A. V. (1991) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y91-153 · Cited by 67 · see citing works

Characterization of high‐affinity receptors for truncated glucagon‐like peptide‐1 in rat gastric glands

UTTENTHAL, L. O., & Blázquez, E. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80173-g · Cited by 66 · see citing works

Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects

EDWARDS, C. M. B., TODD, J. F., Ghatei, M. A., & Bloom, S. R. (1998) · Clinical Science · doi:10.1042/cs0950719 · Cited by 57 · see citing works

Cardiovascular and pancreatic endocrine responses to glucagon‐like peptide‐1(7–36) amide in the conscious calf

EDWARDS, C. L., Edwards, A., & Bloom, S. R. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004059 · Cited by 53 · see citing works

Selective release of glutamine and glutamic acid produced by perfusion of GLP-1(7–36) amide in the basal ganglia of the conscious rat

Mora, F., Expósito, I., Sanz, B., & Blázquez, E. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90068-9 · Cited by 44 · see citing works

Glucagon-Like Peptide-1-(7-36)Amide Increases Pulmonary Surfactant Secretion through a Cyclic Adenosine 3',5'-Monophosphate-Dependent Protein Kinase Mechanism in Rat Type II Pneumocytes

Benito, E., Blázquez, E., & Bosch, M. A. (1998) · Endocrinology · doi:10.1210/endo.139.5.5998 · Cited by 43 · see citing works

Structural Characterization by Affinity Cross‐Linking of Glucagon‐Like Peptide‐1(7–36)Amide Receptor in Rat Brain

Calvo, J. C., Yusta, B., Mora, F., & Blázquez, E. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010299.x · Cited by 42 · see citing works

Characterization of glucagon‐like peptide‐I(7–36)amide receptors of rat lung membranes by covalent cross‐linking

Richter, G., Göke, R., Göke, B., Schmidt, H., & Arnold, R. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80303-k · Cited by 36 · see citing works

A New Twist in the Brain-Gut Axis

Whitcomb, D. C., & Taylor, I. L. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199211000-00001 · Cited by 27 · see citing works

Cardiac dose response relationship for intravenously infused glucagon in normal intact dogs and men

Smitherman, T. C., Osborn, R. C., & Atkins, J. M. (1978) · American Heart Journal · doi:10.1016/0002-8703(78)90048-0 · Cited by 16 · see citing works

Decreased cardiorespiratory effects of neuropeptide Y in the nucleus tractus solitarius in diabetes

Dunbar, J. C., Ergene, E., Anderson, G. F., & Barraco, R. A. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.262.5.r865 · Cited by 10 · see citing works

Biology of Incretins: GLP-1 and GIP

Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · see citing works

The biology of incretin hormones

Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210 · see citing works

Glucagon-like peptide 1 (GLP-1)

Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868 · see citing works

The role of incretins in glucose homeostasis and diabetes treatment

Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824 · see citing works

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease

Nyström, T., Gutniak, M. K., Zhang, Q., Zhang, F., Holst, J. J., Ahrén, B., & Sjöholm, Å. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00237.2004 · Cited by 680 · see citing works

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.

Bose, A. K., Mocanu, M., Carr, R. D., Brand, C. L., & Yellon, D. (2005) · Diabetes · doi:10.2337/diabetes.54.1.146 · Cited by 642 · see citing works

GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice

Noyan-Ashraf, M. H., Momen, M. A., Ban, K., Sadi, A.-M., Zhou, Y.-Q., Riazi, A. M., Baggio, L. L., Henkelman, R. M., Husain, M., & Drucker, D. J. (2009) · Diabetes · doi:10.2337/db08-1193 · Cited by 575 · see citing works

Cardiovascular Biology of the Incretin System

Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 527 · see citing works

Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy

Nikolaidis, L., Elahi, D., Hentosz, T., Doverspike, A., Huerbin, R., Zourelias, L., Stolarski, C. J., Shen, Y.-T., & Shannon, R. (2004) · Circulation · doi:10.1161/01.cir.0000139339.85840.dd · Cited by 546 · see citing works

International Union of Pharmacology. XXXV. The Glucagon Receptor Family

Mayo, K. E., Miller, L. J., BATAILLE, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 507 · see citing works

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.

Yamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J., Lopez, M. E., Hollenberg, A., Baggio, L., Saper, C., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15595 · Cited by 544 · see citing works

Minireview: The Glucagon-Like Peptides

Drucker, D. J. (2001) · Endocrinology · doi:10.1210/endo.142.2.7983 · Cited by 421 · see citing works

The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem

Álvarez, E., Martínez, M. D., Roncero, I., Chowen, J. A., Cuartero, B. G., Gispert, J. D., Sanz, C., Vázquez, P., Maldonado, A., Cáceres, J. D., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02914.x · Cited by 307 · see citing works

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function

Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302 · see citing works

Ophidian envenomation strategies and the role of purines

Aird, S. D. (2002) · Toxicon · doi:10.1016/s0041-0101(01)00232-x · Cited by 300 · see citing works

Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites

Yamamoto, H., Kishi, T., Lee, C. E., Choi, B. J., Fang, H., Hollenberg, A. N., Drucker, D. J., & Elmquist, J. K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02939.2003 · Cited by 294 · see citing works

Glucagon-like peptide 1(GLP-1) in biology and pathology

Meier, J. J., & Nauck, M. A. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.538 · Cited by 288 · see citing works

Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy

Nikolaidis, L. A., Elahi, D., Shen, Y.-T., & Shannon, R. P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00347.2005 · Cited by 274 · see citing works

Caudal Brainstem Processing Is Sufficient for Behavioral, Sympathetic, and Parasympathetic Responses Driven by Peripheral and Hindbrain Glucagon-Like-Peptide-1 Receptor Stimulation

Hayes, M. R., Skibicka, K. P., & Grill, H. J. (2008) · Endocrinology · doi:10.1210/en.2007-1743 · Cited by 214 · see citing works

The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides

Abu‐Hamdah, R., Rabiee, A., Meneilly, G. S., Shannon, R. P., Andersen, D. K., & Elahi, D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1296 · Cited by 202 · see citing works

Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate (Macaca mulatta) Brain

Heppner, K. M., Kirigiti, M. A., Secher, A., Paulsen, S. J., Buckingham, R., Pyke, C., Knudsen, L. B., Vrang, N., & Grove, K. L. (2014) · Endocrinology · doi:10.1210/en.2014-1675 · Cited by 195 · see citing works

Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors

Verspohl, E. J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.002 · Cited by 193 · see citing works

Cardiac Function in Mice Lacking the Glucagon-Like Peptide-1 Receptor

Gros, R., You, X., Baggio, L. L., Kabir, M. G., Sadi, A. M., Mungrue, I. N., Parker, T. G., Huang, Q., Drucker, D. J., & Husain, M. (2003) · Endocrinology · doi:10.1210/en.2003-0007 · Cited by 192 · see citing works

Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism

Nyström, T., Gonon, A. T., Sjöholm, Å., & Pernow, J. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.024 · Cited by 188 · see citing works

The nucleus tractus solitarius: a portal for visceral afferent signal processing, energy status assessment and integration of their combined effects on food intake

Grill, H. J., & Hayes, M. R. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.10 · Cited by 174 · see citing works

Role of the glucagon-like-peptide-1 receptor in the control of energy balance

Hayes, M. R., De Jonghe, B. C., & Kanoski, S. E. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.02.029 · Cited by 173 · see citing works

Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment

Trapp, S., & Brierley, D. I. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15638 · Cited by 154 · see citing works

The effect of glucagon-like peptide 1 on cardiovascular risk

Sivertsen, J., Rosenmeier, J. B., Holst, J. J., & Vilsbøll, T. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.211 · Cited by 147 · see citing works

Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow

Jensen, E. P., Poulsen, S. S., Kissow, H., Holstein-Rathlou, N.-H., Deacon, C. F., Jensen, B. L., Holst, J. J., & Sorensen, C. M. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00527.2014 · Cited by 141 · see citing works

Leptin and the systems neuroscience of meal size control

Grill, H. J. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.10.005 · Cited by 137 · see citing works

Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: Role of peripherally secreted and centrally produced peptides

Vrang, N., & Larsen, P. J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.07.003 · Cited by 134 · see citing works

Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning

Васильевна, Б. М., Mastitskaya, S., Mrochek, A., Ackland, G. L., del Arroyo, A. G., Sanchez, J., Sjöquist, P.-O. B., Pernow, J., Gourine, A. V., & Gourine, A. V. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw216 · Cited by 132 · see citing works

Renal effects of glucagon-like peptide in rats

Moreno, C., Mistry, M., & Roman, R. J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01542-4 · Cited by 121 · see citing works

Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity

Cabou, C., Campistron, G., Marsollier, N., Leloup, C., Cruciani‐Guglielmacci, C., Pénicaud, L., Drucker, D. J., Magnan, C., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db08-0121 · Cited by 121 · see citing works

Emerging cardiovascular actions of the incretin hormone glucagon‐like peptide‐1: potential therapeutic benefits beyond glycaemic control?

Grieve, D., Cassidy, R. S., & Green, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00376.x · Cited by 121 · see citing works

The Glucagon-Like Peptide-1 Receptor Regulates Endogenous Glucose Production and Muscle Glucose Uptake Independent of Its Incretin Action

Ayala, J. E., Bracy, D. P., James, F. D., Julien, B. M., Wasserman, D. H., & Drucker, D. J. (2008) · Endocrinology · doi:10.1210/en.2008-0945 · Cited by 114 · see citing works

Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice

Himeno, T., Kamiya, H., Naruse, K., Harada, N., Ozaki, N., Seino, Y., Shibata, T., Kondo, M., Kato, J., Okawa, T., et al. (2011) · Diabetes · doi:10.2337/db10-1462 · Cited by 112 · see citing works

GLP-1, the Gut-Brain, and Brain-Periphery Axes

Cabou, C., & Burcelin, R. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.418 · Cited by 110 · see citing works

GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons

Griffioen, K. J. S., Wan, R., Okun, E., Wang, X., Lovett-Barr, M. R., Li, Y., Mughal, M. R., Mendelowitz, D., & Mattson, M. P. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq271 · Cited by 110 · see citing works

Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans

Bharucha, A. E., Charkoudian, N., Andrews, C. N., Camilleri, M., Sletten, D., Zinsmeister, A. R., & Low, P. A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00153.2008 · Cited by 98 · see citing works

GLP-1 Agonists and Blood Pressure: A Review of the Evidence

Goud, A., Zhong, J., Peters, M. C., Brook, R. D., & Rajagopalan, S. (2016) · Current Hypertension Reports · doi:10.1007/s11906-015-0621-6 · Cited by 93 · see citing works

GLP-1(7-36)-amide and Exendin-4 Stimulate the HPA Axis in Rodents and Humans

Gil‐Lozano, M., Pérez–Tilve, D., Álvarez-Crespo, M., Martís, A., Fernandez, A. M., Catalina, P. F., González-Matías, L. C., & Mallo, F. (2010) · Endocrinology · doi:10.1210/en.2009-0915 · Cited by 93 · see citing works

Class II G Protein-Coupled Receptors and Their Ligands in Neuronal Function and Protection

Martin, B., de Maturana, R. L., Brenneman, R., Walent, T., Mattson, M. P., & Maudsley, S. R. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:003 · Cited by 89 · see citing works

Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress

Diz-Chaves, Y., Herrera-Pérez, S., González-Matías, L. C., Lamas, J. A., & Mallo, F. (2020) · Nutrients · doi:10.3390/nu12113304 · Cited by 84 · see citing works

Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP ‐ 1R activation

Pabreja, K., Mohd, M. A., Koole, C., Wootten, D. L., & Furness, S. G. B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12313 · Cited by 84 · see citing works

Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system

Osaka, T., Endo, M., Yamakawa, M., & Inoue, S. (2005) · Peptides · doi:10.1016/j.peptides.2005.02.016 · Cited by 84 · see citing works

Extrahypothalamic Expression of the Glucagon-Like Peptide-2 Receptor Is Coupled to Reduction of Glutamate-Induced Cell Death in Cultured Hippocampal Cells

Lovshin, J. A., Huang, Q., Seaberg, R. M., Brubaker, P. L., & Drucker, D. J. (2004) · Endocrinology · doi:10.1210/en.2004-0100 · Cited by 84 · see citing works

Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei

Tauchi, M., Zhang, R., D’Alessio, D. A., Stern, J. E., & Herman, J. P. (2008) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2008.07.009 · Cited by 79 · see citing works

Effects of GLP-1 Receptor Agonists on Heart Rate and the Autonomic Nervous System Using Holter Electrocardiography and Power Spectrum Analysis of Heart Rate Variability

Nakatani, Y., Kawabe, A., Matsumura, M., Aso, Y., Yasu, T., Banba, N., & Nakamoto, T. (2016) · Diabetes Care · doi:10.2337/dc15-1437 · Cited by 77 · see citing works

Glucagon-like peptide-1 and glucagon-like peptide-2

Baggio, L. L., & Drucker, D. J. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.08.001 · Cited by 73 · see citing works

Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance

Pujadas, G., & Drucker, D. J. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1078 · Cited by 63 · see citing works

Potential side effects to GLP-1 agonists: understanding their safety and tolerability

Consoli, A., & Formoso, G. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.987122 · Cited by 63 · see citing works

Effects of centrally or systemically injected glucagon-like peptide-1 (7–36) amide on release of neurohypophysial hormones and blood pressure in the rat

Bojanowska, E., & Stempniak, B. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00119-1 · Cited by 62 · see citing works

Regulation of lipid metabolism by energy availability: a role for the central nervous system

Nogueiras, R., López, M., & Diéguez, C. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00669.x · Cited by 62 · see citing works

Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous system

Pérez–Tilve, D., González-Matías, L. C., Aulinger, B. A., Álvarez-Crespo, M., Gil‐Lozano, M., Alvarez, E., Andrade-Olivie, A. M., Tschöp, M. H., D’Alessio, D. A., & Mallo, F. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00464.2009 · Cited by 61 · see citing works

Multifaceted Roles of GLP-1 and Its Analogs: A Review on Molecular Mechanisms with a Cardiotherapeutic Perspective

Pandey, S., Mangmool, S., & Parichatikanond, W. (2023) · Pharmaceuticals · doi:10.3390/ph16060836 · Cited by 58 · see citing works

Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor

Sowden, G. L., Drucker, D. J., Weinshenker, D., & Swoap, S. J. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00405.2006 · Cited by 57 · see citing works

Mesenteric Vasoconstriction and Hindquarters Vasodilatation Accompany the Pressor Actions of Exendin-4 in Conscious Rats

Gardiner, S. M., March, J. E., Kemp, P. A., & Bennett, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093104 · Cited by 50 · see citing works

Cardiorenal mechanisms of action of glucagon-like-peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors

Cherney, D. Z. I., Udell, J. A., & Drucker, D. J. (2021) · Med · doi:10.1016/j.medj.2021.10.004 · Cited by 52 · see citing works

Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin

Işbil-Büyükcoşkun, N., & Süyen, G. G. (2003) · Regulatory Peptides · doi:10.1016/j.regpep.2003.10.025 · Cited by 49 · see citing works

Hypoglycemic pharmacological treatment of type 2 diabetes: Targeting the endothelium

Nathanson, D., & Nyström, T. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.016 · Cited by 48 · see citing works

The role of nucleus of the solitary tract glucagon‐like peptide‐1 and prolactin‐releasing peptide neurons in stress: anatomy, physiology and cellular interactions

Holt, M. K., & Rinaman, L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15576 · Cited by 44 · see citing works

Extra‐pancreatic effects of incretin‐based therapies: potential benefit for cardiovascular‐risk management in type 2 diabetes

van Genugten, R. E., Möller-Goede, D. L., van Raalte, D. H., & Diamant, M. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12050 · Cited by 46 · see citing works

Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats

Katsurada, K., Nakata, M., Saito, T., Zhang, B., Maejima, Y., Nandi, S. S., Sharma, N. M., Patel, K. P., Kario, K., & Yada, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-49364-x · Cited by 46 · see citing works

A Possible Role of GLP-1 in the Pathophysiology of Early Dumping Syndrome

Yamamoto, H., Mori, T., Tsuchihashi, H., Akabori, H., Naito, H., & Tani, T. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-3046-2 · Cited by 43 · see citing works

Pleiotropic Actions of the Incretin Hormones

McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00002-3 · Cited by 40 · see citing works

The gut-brain axis: a major glucoregulatory player

Burcelin, R. (2010) · Diabetes & Metabolism · doi:10.1016/s1262-3636(10)70468-7 · Cited by 37 · see citing works

PPG neurons in the nucleus of the solitary tract modulate heart rate but do not mediate GLP-1 receptor agonist-induced tachycardia in mice

Holt, M. K., Cook, D. R., Brierley, D. I., Richards, J. E., Reimann, F. M., Gourine, A. V., Marina, N., & Trapp, S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101024 · Cited by 35 · see citing works

Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3

Tsutsumi, Y. M., Tsutsumi, R., Hamaguchi, E., Sakai, Y., Kasai, A., Ishikawa, Y., Yokoyama, U., & Tanaka, K. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0132-9 · Cited by 35 · see citing works

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., den Bos, I. C. P.-V., Cahen, D. L., Diamant, M., & van Raalte, D. H. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009579 · Cited by 31 · see citing works

GLP-1R activation for the treatment of stroke: Updating and future perspectives

Darsalia, V., Nathanson, D., Nyström, T., Klein, T., Sjöholm, Å., & Patrone, C. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9285-9 · Cited by 30 · see citing works

Effects of prolonged exendin-4 administration on hypothalamic-pituitary-adrenal axis activity and water balance

Gil‐Lozano, M., Romaní‐Pérez, M., Outeiriño‐Iglesias, V., Vigo, E., Brubaker, P. L., González-Matías, L. C., & Mallo, F. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00529.2012 · Cited by 29 · see citing works

Possible involvement of GLP‐1(9–36) in the regional haemodynamic effects of GLP‐1(7–36) in conscious rats

Gardiner, S., March, J., Kemp, P. A., Bennett, T. M., & Dj, B. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00867.x · Cited by 28 · see citing works

Mechanisms for the cardiovascular effects of glucagon-like peptide-1

Poudyal, H. (2015) · Acta Physiologica · doi:10.1111/apha.12604 · Cited by 28 · see citing works

Autonomic nervous system‐dependent and ‐independent cardiovascular effects of exendin‐4 infusion in conscious rats

Gardiner, S. M., March, J. E., Kemp, P. A., & Bennett, T. M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.75 · Cited by 28 · see citing works

Pleiotropic effects of insulin and GLP-1 receptor agonists: Potential benefits of the association

Cariou, B. (2015) · Diabetes & Metabolism · doi:10.1016/s1262-3636(16)30006-4 · Cited by 28 · see citing works

Glucagon-Like Peptide 1—A Cardiologic Dimension

Treiman, M., Elvekjær, M., Engstrøm, T., & Jensen, J. S. (2010) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2010.02.012 · Cited by 27 · see citing works

GLP-1-induced renal vasodilation in rodents depends exclusively on the known GLP-1 receptor and is lost in prehypertensive rats

Jensen, E. P., Møller, S., Hviid, A. V., Veedfald, S., Holst, J. J., Pedersen, J., Ørskov, C., & Sørensen, C. M. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00579.2019 · Cited by 27 · see citing works

Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass

Dailey, M. J., Moghadam, A. A., & Moran, T. H. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00335.2011 · Cited by 26 · see citing works

Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1

Clarke, S. J., McCormick, L. M., & Dutka, D. P. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-12 · Cited by 25 · see citing works

Effects of Glucagon-Like Peptide-1 and Long-Acting Analogues on??Cardiovascular and Metabolic Function

Saraceni, C., & Broderick, T. L. (2007) · Drugs in R&D · doi:10.2165/00126839-200708030-00002 · Cited by 22 · see citing works

Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects

Lymperopoulos, A., Borges, J. I., & Stoicovy, R. A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060693 · Cited by 18 · see citing works

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Hypothalamic-Pituitary-Adrenal Axis in Healthy Volunteers

Winzeler, B. F., da Conceição, I., Refardt, J. C., Sailer, C. O., Dutilh, G., & Christ‐Crain, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01420 · Cited by 18 · see citing works

Glucagon-like peptide-1 (7–36) but not (9–36) augments cardiac output during myocardial ischemia via a Frank–Starling mechanism

Goodwill, A. G., Tune, J. D., Noblet, J. N., Conteh, A. M., Sassoon, D., Casalini, E. D., & Mather, K. J. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0426-9 · Cited by 18 · see citing works

Harnessing the incretin system beyond glucose control: Potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetes

Cariou, B. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.04.003 · Cited by 18 · see citing works

Cardiovascular and hemodynamic effects of glucagon-like peptide-1

Goodwill, A. G., Mather, K. J., Conteh, A. M., Sassoon, D., Noblet, J. N., & Tune, J. D. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9290-z · Cited by 17 · see citing works

Multifactorial intervention in Type 2 diabetes: The promise of incretin-based therapies

Giorgino, F., Leonardini, A., Natalicchio, A., & Laviola, L. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346698 · Cited by 17 · see citing works

Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel‐group study

Nyström, T., Santos‐Pardo, I., Fang, X. L., Cao, Y., Hedberg, F., & JENDLE, J. H. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.58 · Cited by 17 · see citing works

Elevated blood pressure, heart rate and body temperature in mice lacking the XLαs protein of the <i>Gnas</i> locus is due to increased sympathetic tone

Nunn, N., Feetham, C. H., Martin, J., Barrett‐Jolley, R., & Plagge, A. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2013.073064 · Cited by 17 · see citing works

Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists

Gallwitz, B. (2009) · The Review of Diabetic Studies · doi:10.1900/rds.2009.6.247 · Cited by 17 · see citing works

Effects of glucagon-like peptide-1(7-36) amide on neurohypophysial and cardiovascular functions under hypo- or normotensive hypovolaemia in the rat

Bojanowska, E., & Stempniak, B. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720303 · Cited by 15 · see citing works

tGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effects of a tGLP-1 receptor agonist and antagonist.

Bojanowska, E., & Stempniak, B. (2001) · PubMed · Cited by 12 · see citing works

Immunohistochemical determination of the site of hypotensive effects of glucagon-like peptide-2 in the rat brain

Sasaki‐Hamada, S., Okada, S., Ito, K. L., Iwai, T., & Oka, J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.032 · Cited by 11 · see citing works

Investigation of the mechanisms involved in the central effects of glucagon-like peptide-1 on ethanol-induced gastric mucosal lesions

Isbil-Buyukcoskun, N., & Gulec, G. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.12.019 · Cited by 10 · see citing works

Peripheral GLP-1 gastroprotection against ethanol: The role of exendin, NO, CGRP, prostaglandins and blood flow

Işbil-Büyükcoşkun, N., Süyen, G. G., Çam-Etöz, B., & Özlük, K. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.09.006 · Cited by 10 · see citing works

Effect of peripherally-injected glucagon-like peptide-1 on gastric mucosal blood flow

Işbil-Büyükcoşkun, N., Çam-Etöz, B., Süyen, G. G., & Özlük, K. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.04.013 · Cited by 10 · see citing works

Exploiting the pleiotropic actions of GLP-1 for the management of type 2 diabetes mellitus and its complications

Giorgino, F., Natalicchio, A., Leonardini, A., & Laviola, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.09.022 · Cited by 10 · see citing works

Expression of glucagon‐like peptide‐1 (GLP‐1) receptor and the effect of GLP‐1‐(7–36) amide on insulin release by pancreatic islets during rat ontogenic development

García‐Flores, M., Zueco, J. A., Álvarez, E., & Blázquez, E. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01865.x · Cited by 10 · see citing works

An Interaction between Hypothalamic Glucagon-Like Peptide-1 and Macronutrient Composition Determines Food Intake in Rats

Choi, Y., & Anderson, G. H. (2001) · Journal of Nutrition · doi:10.1093/jn/131.6.1819 · Cited by 10 · see citing works

Modulation of stress-related behaviour by preproglucagon neurons and hypothalamic projections to the nucleus of the solitary tract

Holt, M. K., Valderrama, N., Polanco, M. J., Hayter, I., Badenoch, E. G., Trapp, S., & Rinaman, L. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102076 · Cited by 13 · see citing works

Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin

Işbil-Büyükcoşkun, N., & Süyen, G. G. (2003) · Regulatory Peptides · doi:10.1016/j.regpep.2003.10.025 · Cited by 49 · see citing works

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

Yamamoto, H., Lee, C. E., Marcus, J., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L. L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215595 · Cited by 35 · see citing works

GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons

Griffioen, K. J. S., Wan, R., Okun, E., Wang, X., Lovett-Barr, M. R., Li, Y., Mughal, M. R., Mendelowitz, D., & Mattson, M. P. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq271 · Cited by 110 · see citing works

Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats.

Barragán, J., Rodríguez, R. E., & Blázquez, E. (1994) · American Journal of Physiology · doi:10.1152/ajpendo.1994.266.3.e459 · Cited by 207 · see citing works

Effects of centrally or systemically injected glucagon-like peptide-1 (7–36) amide on release of neurohypophysial hormones and blood pressure in the rat

Bojanowska, E., & Stempniak, B. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00119-1 · Cited by 62 · see citing works